Entegris (ENTG) | Financial Analysis & Statements
Entegris Inc. Large-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
823.9M
Gross Profit
360.6M
43.77%
Operating Income
569.5M
69.12%
Net Income
49.4M
6.00%
EPS (Diluted)
$0.32
Balance Sheet Metrics
Total Assets
8.4B
Total Liabilities
4.4B
Shareholders Equity
4.0B
Debt to Equity
1.11
Cash Flow Metrics
Operating Cash Flow
132.7M
Free Cash Flow
134.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Entegris Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.2B | 3.2B | 3.5B | 3.3B | 2.3B |
| Cost of Goods Sold | 1.8B | 1.8B | 2.0B | 1.9B | 1.2B |
| Gross Profit | 1.4B | 1.5B | 1.5B | 1.4B | 1.1B |
| Gross Margin % | 44.4% | 45.9% | 42.5% | 42.5% | 46.1% |
| Operating Expenses | |||||
| Research & Development | 329.0M | 316.1M | 277.3M | 229.0M | 167.6M |
| Selling, General & Administrative | -17.0M | 553.3M | 426.2M | 543.5M | 292.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 312.0M | 869.4M | 703.5M | 772.5M | 460.0M |
| Operating Income | 923.5M | 435.1M | 579.6M | 480.0M | 551.8M |
| Operating Margin % | 28.9% | 13.4% | 16.4% | 14.6% | 24.0% |
| Non-Operating Items | |||||
| Interest Income | 7.9M | 7.4M | 11.3M | 3.7M | 243.0K |
| Interest Expense | 199.8M | 215.2M | 312.4M | 212.7M | 41.2M |
| Other Non-Operating Income | -477.0M | 94.8M | -105.8M | -23.9M | -31.7M |
| Pre-tax Income | 254.6M | 322.1M | 172.7M | 247.1M | 479.1M |
| Income Tax | 18.0M | 28.3M | -8.4M | 38.2M | 70.0M |
| Effective Tax Rate % | 7.1% | 8.8% | -4.9% | 15.4% | 14.6% |
| Net Income | 235.6M | 292.8M | 180.7M | 208.9M | 409.1M |
| Net Margin % | 7.4% | 9.0% | 5.1% | 6.4% | 17.8% |
| Key Metrics | |||||
| EBITDA | 1.3B | 818.7M | 977.4M | 765.4M | 689.7M |
| EPS (Basic) | $1.55 | $1.94 | $1.21 | $1.47 | $3.02 |
| EPS (Diluted) | $1.55 | $1.93 | $1.20 | $1.46 | $3.00 |
| Basic Shares Outstanding | 151700000 | 150946000 | 149900000 | 142294000 | 135411000 |
| Diluted Shares Outstanding | 151700000 | 150946000 | 149900000 | 142294000 | 135411000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Entegris Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 360.4M | 329.2M | 456.9M | 561.6M | 402.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 462.5M | 497.3M | 457.6M | 536.3M | 347.1M |
| Inventory | 643.2M | 638.1M | 607.1M | 812.8M | 475.2M |
| Other Current Assets | 140.8M | 108.6M | 113.7M | 129.3M | 52.9M |
| Total Current Assets | 1.6B | 1.6B | 2.0B | 2.3B | 1.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.3B | 1.2B | 1.0B | 909.1M | 702.3M |
| Goodwill | 8.8B | 9.0B | 9.2B | 10.7B | 1.9B |
| Intangible Assets | 906.9M | 1.1B | 1.3B | 1.8B | 335.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 113.9M | 36.6M | 59.0M | 65.1M | 29.0M |
| Total Non-Current Assets | 6.7B | 6.8B | 6.8B | 7.8B | 1.9B |
| Total Assets | 8.4B | 8.4B | 8.8B | 10.1B | 3.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 171.5M | 193.3M | 134.2M | 172.5M | 130.7M |
| Short-term Debt | - | - | - | 152.0M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 1.2M | 19.2M | 10.6M | - |
| Total Current Liabilities | 488.6M | 525.2M | 514.0M | 761.9M | 379.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.8B | 4.1B | 4.6B | 5.7B | 997.1M |
| Deferred Tax Liabilities | 40.8M | 70.2M | 190.1M | 391.2M | 64.2M |
| Other Non-Current Liabilities | 71.5M | - | - | - | - |
| Total Non-Current Liabilities | 3.9B | 4.2B | 4.9B | 6.2B | 1.1B |
| Total Liabilities | 4.4B | 4.7B | 5.4B | 6.9B | 1.5B |
| Equity | |||||
| Common Stock | 1.5M | 1.5M | 1.5M | 1.5M | 1.4M |
| Retained Earnings | 1.6B | 1.4B | 1.2B | 1.0B | 879.8M |
| Treasury Stock | 7.1M | 7.1M | 7.1M | 7.1M | 7.1M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.0B | 3.7B | 3.4B | 3.2B | 1.7B |
| Key Metrics | |||||
| Total Debt | 3.8B | 4.1B | 4.6B | 5.9B | 997.1M |
| Working Capital | 1.1B | 1.1B | 1.5B | 1.6B | 934.4M |
Balance Sheet Composition
Entegris Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 235.6M | 292.8M | 180.7M | 208.9M | 409.1M |
| Depreciation & Amortization | 389.7M | 378.2M | 387.2M | 279.3M | 138.2M |
| Stock-Based Compensation | 69.3M | 65.9M | 61.4M | 66.6M | 29.9M |
| Working Capital Changes | -7.3M | -109.0M | 60.7M | -260.1M | -193.4M |
| Operating Cash Flow | 669.6M | 609.7M | 442.4M | 327.2M | 380.4M |
| Investing Activities | |||||
| Capital Expenditures | -299.2M | -315.6M | -456.8M | -466.2M | -210.6M |
| Acquisitions | -6.7M | 250.8M | 815.0M | -4.5B | -91.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -300.8M | -67.1M | 553.1M | -4.9B | -298.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | 0 | 0 | -67.1M |
| Dividends Paid | -60.8M | -60.6M | -60.2M | -57.3M | -43.5M |
| Debt Issuance | 567.0M | 364.5M | 217.4M | 5.4B | 501.0M |
| Debt Repayment | -867.0M | -988.3M | -1.5B | -486.0M | -651.0M |
| Financing Cash Flow | -373.6M | -703.0M | -1.5B | 4.9B | -301.2M |
| Free Cash Flow | 396.2M | 316.1M | 172.7M | -113.9M | 189.8M |
| Net Change in Cash | -4.8M | -160.4M | -473.0M | 266.6M | -219.0M |
Cash Flow Trend
Entegris Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
95.44
Forward P/E
33.39
Price to Book
5.68
Price to Sales
7.05
PEG Ratio
-1.85
Profitability Ratios
Profit Margin
7.37%
Operating Margin
14.23%
Return on Equity
6.16%
Return on Assets
3.63%
Financial Health
Current Ratio
3.35
Debt to Equity
96.42
Beta
1.32
Per Share Data
EPS (TTM)
$1.55
Book Value per Share
$26.03
Revenue per Share
$21.07
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ENTG | 22.7B | 95.44 | 5.68 | 6.16% | 7.37% | 96.42 |
| Lam Research | 324.8B | 54.64 | 32.75 | 65.57% | 30.22% | 44.20 |
| Applied Materials | 331.0B | 42.91 | 15.26 | 38.86% | 27.78% | 33.11 |
| Teradyne | 62.8B | 114.90 | 22.39 | 19.73% | 17.37% | 10.13 |
| Amkor Technology | 19.4B | 48.61 | 4.03 | 8.66% | 5.57% | 36.97 |
| Nova | 16.6B | 66.47 | 12.72 | 23.08% | 29.44% | 60.62 |
Financial data is updated regularly. All figures are in the company's reporting currency.






